Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Dexamethasone (40 mg tablet)

EU orphan designation number: EU/3/10/745   
Active ingredient: Dexamethasone (40 mg tablet)
Indication: Treatment of multiple myeloma
Sponsor: Laboratoires CTRS (Cell Therapies Research & Services)
69 rue de l'Est, F-92100 Boulogne-Billancourt, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2010 Centralised Orphan - Designation EMEA/OD/133/09 (2010)3838 of 09/06/2010